---
title: "Avid Bioservices (CDMO.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/CDMO.US.md"
symbol: "CDMO.US"
name: "Avid Bioservices"
industry: "生物技術"
---

# Avid Bioservices (CDMO.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |

## Company Profile

Avid Bioservices, Inc. 是一家位于美國的生物技術和生物制藥行業的合同開發和制造組織。該公司提供生物制品的工藝開發和符合良好制造規範的臨床和商業生產服務，包括臨床和商業藥物物質生產、散裝包裝、釋放和穩定性測試、監管提交和支持、上遊和下遊開發和優化、分析方法開發、細胞系開發、測試和表徵服務。該公司以前被稱為 Peregrine Pharmaceuticals, Inc

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-19T04:30:16.000Z

**Overall: D (0.72)**

**Industry**: Biotechnology

| Metric | Value |
|--------|-------|
| Industry Median | D |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.75% |  |
| Net Profit YoY | -1143.76% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 0.00 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 0.00 |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 150.44M |  |


**Multi Score**: D

#### Profit Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | -133.29% | E |
| Profit Margin | -101.07% | E |
| Gross Margin | -6.11% | E |

#### Growth Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 6.75% | C |
| Net Profit YoY | -1143.76% | E |
| Total Assets YoY | -28.98% | E |
| Net Assets YoY | -75.56% | E |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -98.94% | D |
| OCF YoY | 6.75% | C |

#### Operating Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.39 | C |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 86.15% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Avid Bioservices",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "E",
      "indicators": [
        {
          "name": "ROE",
          "value": "-133.29%",
          "rating": "E"
        },
        {
          "name": "Profit Margin",
          "value": "-101.07%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "-6.11%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "D",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "6.75%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-1143.76%",
          "rating": "E"
        },
        {
          "name": "Total Assets YoY",
          "value": "-28.98%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-75.56%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-98.94%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "6.75%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "C",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.39",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "86.15%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | ADMA生物制藥 (US.ADMA) | A | A | A | B | B | A |
| 02 | Kiniksa Pharmaceuticals (US.KNSA) | B | A | A | B | A | A |
| 03 | Stoke Therapeutics (US.STOK) | A | A | B | A | B | A |
| 04 | OpGen (US.OPGN) | B | A | A | A | B | A |
| 05 | 艾伯維 (US.ABBV) | A | C | E | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 12.49 |
| Highest Target | 14.00 |
| Lowest Target | 12.50 |

## References

- [Company Overview](https://longbridge.com/en/quote/CDMO.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/CDMO.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/CDMO.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.